Body Composition and Metabolic Syndrome Components on Lipodystrophy Different Subtypes Associated with HIV

Table 5

Clinical-immunological people living with HIV/AIDS profile with clinical HIV-associated lipodystrophy syndrome diagnosis separated by HIV-associated lipodystrophy syndrome subtypes.

	Mixed; ()	Lipoatrophy; ()	Lipohypertrophy; ()	value
Age (years)	44,9 ± 8,4	49,3 ± 7,4	41,6 ± 7,6	0,0736
Diagnostic period (years)	15,1 ± 6,0	16,1 ± 7,4	14,8 ± 5,1	0,8681
ART period (years)	13,7 ± 6,0	14,2 ± 5,7	13,3 ± 6,0	0,9556
TCD4+ (cells/mm^3)		747,3 ± 432,7		0,0586
TCD8+ (cells/mm^3)	991,4 ± 376,5	934,7 ± 354,4	972,3 ± 314,3	0,9140

ART: antiretroviral therapy; TCD+: lymphocyte T; cells/mm³: cells per cubic millimeter.
Note. difference between HALS mixed group and HALS lipohypertrophy group.